Artigo de periodico

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study (2014)

• Authors:
  • Lalonde, Emilie
  • Ishkanian, Adrian S.
  • Sykes, Jenna
  • Fraser, Michael
  • Ross-Adams, Helen
  • Erho, Nicholas
  • Dunning, Mark
  • Halim, Silvia
  • Lamb, Alastair D.
  • Moon, Nathalie C.
  • Zafarana, Gaetano
  • Warren, Anne Y.
  • Meng, Xianyue
  • Thoms, John
  • Grzadkowski, Michal R.
  • Berlin, Alejandro
  • Have, Cherry L.
  • Rammarine, Varune R.
  • Yao, Cindy Q.
  • Malloff, Chad A.
  • Lam, Lucia L.
  • Xie, Honglei
  • Harding, Nicholas J.
  • Mak, Denise Y. F.
  • Chu, Kenneth C.
  • Chong, Lauren C.
  • Sendorek, Dorota H.
  • P'ng, Christine
  • Collins, Colin C.
  • Squire, Jeremy A.
  • Jurisica, Igor
  • Cooper, Colin
  • Eeles, Rosalind
  • Pintillie, Melania
  • Dal Pra, Alan
  • Davicioni, Elai
  • Lam, Wan L.
  • Milosevic, Michael
  • Neal, David E.
  • van der Kwast, Theodorus
  • Boutros, Paul C
  • Bristow, Robert G.
• Autor USP: SQUIRE, JEREMY ANDREW - FMRP
• Unidade: FMRP
• DOI: 10.1016/S1470-2045(14)71021-6
• Subjects: NEOPLASIAS PROSTÁTICAS (GENÉTICA); EXPRESSÃO GÊNICA; BIOMARCADORES; ANÁLISE DE SEQUÊNCIA DE DNA
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2014
• Source:
  • Título: Lancet Oncology
  • ISSN: 1470-2045
  • Volume/Número/Paginação/Ano: v. 15, n. 13, p. 1521-1532, 2014

Informações sobre o DOI: 10.1016/S1470-2045(14)71021-6 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: cc-by

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  LALONDE, Emilie et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncology, v. 15, n. 13, p. 1521-1532, 2014Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(14)71021-6. Acesso em: 28 dez. 2025.

• APA

  Lalonde, E., Ishkanian, A. S., Sykes, J., Fraser, M., Ross-Adams, H., Erho, N., et al. (2014). Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncology, 15( 13), 1521-1532. doi:10.1016/S1470-2045(14)71021-6

• NLM

  Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning M, Halim S, Lamb AD, Moon NC, Zafarana G, Warren AY, Meng X, Thoms J, Grzadkowski MR, Berlin A, Have CL, Rammarine VR, Yao CQ, Malloff CA, Lam LL, Xie H, Harding NJ, Mak DYF, Chu KC, Chong LC, Sendorek DH, P'ng C, Collins CC, Squire JA, Jurisica I, Cooper C, Eeles R, Pintillie M, Dal Pra A, Davicioni E, Lam WL, Milosevic M, Neal DE, van der Kwast T, Boutros PC, Bristow RG. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study [Internet]. Lancet Oncology. 2014 ; 15( 13): 1521-1532.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/S1470-2045(14)71021-6

• Vancouver

  Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning M, Halim S, Lamb AD, Moon NC, Zafarana G, Warren AY, Meng X, Thoms J, Grzadkowski MR, Berlin A, Have CL, Rammarine VR, Yao CQ, Malloff CA, Lam LL, Xie H, Harding NJ, Mak DYF, Chu KC, Chong LC, Sendorek DH, P'ng C, Collins CC, Squire JA, Jurisica I, Cooper C, Eeles R, Pintillie M, Dal Pra A, Davicioni E, Lam WL, Milosevic M, Neal DE, van der Kwast T, Boutros PC, Bristow RG. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study [Internet]. Lancet Oncology. 2014 ; 15( 13): 1521-1532.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/S1470-2045(14)71021-6

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
• Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
• Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
• Extracellular vesicles: evolving factors in stem cell biology
• The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
• Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
• Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
• In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
• Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
• PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy